Immunotherapy

Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer
Myrto K Moutafi, Weiwei Tao, Richard Huang, James Haberberger, Brian Alexander, Shakti Ramkissoon, Jeffrey S Ross, Konstantinos Syrigos, Wei Wei, Lajos Pusztai, David L Rimm, Ioannis A Vathiotis

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002230; DOI: 10.1136/jitc-2020-002230
Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial
Bo Zhang, Jing Huang, Jialin Tang, Sheng Hu, Suxia Luo, Zhiguo Luo, Fuxiang Zhou, Shiyun Tan, Jieer Ying, Qing Chang, Rui Zhang, Chengyun Geng, Dawei Wu, Xiangyong Gu, Binlei Liu

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002224; DOI: 10.1136/jitc-2020-002224
Rapid corticosteroid taper versus standard of care for immune checkpoint inhibitor induced nephritis: a single-center retrospective cohort study
Meghan D Lee, Harish Seethapathy, Ian A Strohbehn, Sophia H Zhao, Genevieve M Boland, Riley Fadden, Ryan Sullivan, Kerry L Reynolds, Meghan E Sise

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002292; DOI: 10.1136/jitc-2020-002292
CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation
Ryan Michael Reyes, Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler, Harshita B Gupta, Alvaro S Padron, Aravind Kancharla, Chenghao Zhang, Myrna Garcia, Anand V R Kornepati, Onur Boyman, Jose R Conejo-Garcia, Robert S Svatek, Tyler J Curiel

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002051; DOI: 10.1136/jitc-2020-002051
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers
Rivka R Colen, Christian Rolfo, Murat Ak, Mira Ayoub, Sara Ahmed, Nabil Elshafeey, Priyadarshini Mamindla, Pascal O Zinn, Chaan Ng, Raghu Vikram, Spyridon Bakas, Christine B Peterson, Jordi Rodon Ahnert, Vivek Subbiah, Daniel D Karp, Bettzy Stephen, Joud Hajjar, Aung Naing

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e001752; DOI: 10.1136/jitc-2020-001752
Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy
Dong Ho Shin, Teresa Nguyen, Bulent Ozpolat, Frederick Lang, Marta Alonso, Candelaria Gomez-Manzano, Juan Fueyo

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002086; DOI: 10.1136/jitc-2020-002086
Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors
Giovanni Fucà, Francesca Corti, Margherita Ambrosini, Rossana Intini, Massimiliano Salati, Elisabetta Fenocchio, Paolo Manca, Chiara Manai, Francesca Daniel, Alessandra Raimondi, Federica Morano, Salvatore Corallo, Michele Prisciandaro, Andrea Spallanzani, Virginia Quarà, Carmen Belli, Marta Vaiani, Giuseppe Curigliano, Chiara Cremolini, Filippo De Braud, Maria Di Bartolomeo, Vittorina Zagonel, Sara Lonardi, Filippo Pietrantonio

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002501; DOI: 10.1136/jitc-2021-002501
Exploration of modified progression-free survival as a novel surrogate endpoint for overall survival in immuno-oncology trials
Zi-Xian Wang, Hao-Xiang Wu, Li Xie, Wu-Hao Lin, Fei Liang, Jin Li, Zhi-Min Yang, Rui-Hua Xu

Journal for ImmunoTherapy of Cancer Apr 2021, 9 (4) e002114; DOI: 10.1136/jitc-2020-002114
Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
Venky Ramakrishna, Karuna Sundarapandiyan, Biwei Zhao, Max Bylesjo, Henry C. Marsh, Tibor Keler

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 37; DOI: 10.1186/s40425-015-0080-2
Mismatch repair deficiency associated with complete remission to combination programmed cell death ligand immune therapy in a patient with sporadic urothelial carcinoma: immunotheranostic considerations
Michael P. Castro, Neal Goldstein

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (1) 58; DOI: 10.1186/s40425-015-0104-y

Main menu

Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy

Pages